Riskpilot← Back to searchSign inGet full accessAB Optifit Health
ABActiveOrg 5590974050Sturegatan 18Medical specialists activities · NACE 8622Est. 201710-19 employees
Revenue 2024
SEK 4,5M
+3068% vs 2023
EBITDA margin
-40.2%
-30127% vs 2023
Equity ratio
-117.3%
Financial strength
Net profit 2024
SEK -1,8M
-26035% vs 2023
| Revenue | SEK 4,5M | +3068% |
| EBITDA | SEK -1,8M | -30127% |
| Net profit | SEK -1,8M | -26035% |
| Total assets | SEK 812K | +536% |
| Equity | SEK -952K | -2312% |
| Employees | — | — |
Legal name
AB Optifit Health
Org number
5590974050
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 januari 2017
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Styrelsen ska bestå av 4 styrelseledamöter och 0 styrelsesuppleanter.
Company purpose
Bolaget skall bedriva behandling av patienter genom digital vård, fysisk vård och därtill förenlig verksamhet.
Address
Sturegatan 18
Email
info@optifit.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 143 | 4 520 |
| Staff expenses | — | — | — | — | −2 420 |
| EBITDA | −1 | −12 | −6 | −6 | −1 819 |
| Depreciation & amort. | −0 | −0 | — | — | −1 |
| EBIT | −1 | −12 | −6 | −6 | −1 820 |
| Net financials | — | — | −30 | −1 | −0 |
| Profit before tax | −1 | −12 | −36 | −7 | −1 820 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −1 | −12 | −36 | −7 | −1 820 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 45 | 45 | 73 | 128 | 812 |
| Equity | −229 | −241 | 50 | 43 | −952 |
| Long-term debt | 223 | 223 | 0 | — | — |
| Short-term debt | 50 | 63 | 23 | 85 | 1 764 |
| Total debt | 273 | 286 | 23 | 85 | 1 764 |
EBITDA margin
-40.2%
This company
15.8%
Market median
-354% vs market
20202024
Equity ratio
-117.3%
This company
38.2%
Market median
-407% vs market
20202024
Return on equity
-182005800.0%
This company
18.4%
Market median
-989162057% vs market
20202024
Net profit margin
-40.3%
This company
8.1%
Market median
-598% vs market
20202024
Asset turnover
5.57×
This company
1.12×
Market median
+397% vs market
20202024
Debt / equity
1.85×
This company
0.62×
Market median
-198% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2026 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Chairman | 2025 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Optifit Health also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Erik Roger Olsson | Deputy Board Member | 0 companies |
| Johan Eric Magnus Wahlström | Chairman | 0 companies |
| Stefan Hans Olof Köhler | Board of Directors | 0 companies |
| Elias Jokhadar | Board of Directors | 0 companies |
| Sara Maria Olsson | Board of Directors | 0 companies |
| Rikard Hegelund | Chairman | 0 companies |